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Abstract 
  The central oscillator of the cyanobacterial circadian clock is unique in the 
biochemical simplicity of its components and the robustness of the oscillation. The 
oscillator is composed of three cyanobacterial proteins, KaiA, KaiB, and KaiC. If very 
pure preparations of these three proteins are mixed in a test tube in the right proportions 
and with ATP and MgCl2, the phosphorylation states of KaiC will oscillate with a 
circadian period and these states can be analyzed simply by SDS-PAGE. The purity of 
the proteins is critical for obtaining robust oscillation. Contaminating proteases will 
destroy oscillation by degradation of Kai proteins, and ATPases will attenuate 
robustness by consumption of ATP. Here, we provide a detailed protocol to obtain pure 
recombinant proteins from Escherichia coli to construct a robust cyanobacterial 
circadian oscillator in vitro. In addition, we present a protocol that facilitates analysis 
of phosphoryation states of KaiC and other phosphorylated proteins from in vivo 
samples. 
 
1. Theory 
 Circadian clocks are complicated biochemical mechanisms that temporally 
regulate biological processes and the expression of many genes. Many circadian clock 
components have been discovered in an array of organisms by in vivo experiments. 
Because of the complexity of circadian systems in eukaryotic organisms, the relatively 
simple prokaryotic clock of cyanobacteria has been developed as a paradigm for 
circadian biology, and its molecular mechanism can be studied in exquisite detail. The 
three-dimensional structures of the key protein components of the central oscillator, 
KaiA (Ye, Vakonakis, Ioerger, LiWang, & Sacchettini, 2004), KaiB (Villarreal, 
Pattanayek, Williams, Mori, Qin, & Johnson, 2013), and KaiC (Pattanayek, Wang, 
Mori, Xu, Johnson, & Egli, 2004), have been solved at high resolution. Importantly, the 
24-hour rhythm of KaiC phosphorylation can be reconstituted by mixing purified KaiA, 
KaiB, and KaiC with adenosine triphosphate (ATP) in vitro (Nakajima, Imai, Ito, 
Nishiwaki, Murayama, & Iwasaki, 2005). 
 Before the in vitro oscillator was developed, the expected model for circadian 
oscillation in cyanobacteria was that of a transcription-translation feedback loop 
mechanism, as is typically observed in eukaryotic systems. Takao Kondo and co-
workers (Nagoya University) then discovered that the oscillation of KaiC 
phosphorylation continues in cyanobacteria even when translation or transcription is 
blocked (Tomita, Nakajima, Kondo, & Iwasaki, 2005); this finding led them to 
reconstitute the oscillator in vitro. Rhythms of KaiC phosphorylation are readily 
detected, both in vivo and in vitro, via SDS-PAGE analysis. Use of the in vitro 
oscillator allows researchers to identify specific steps in the biochemical mechanism of 
the circadian clock at the molecular level.  
 The purification of the three oscillator proteins is a crucial technique to construct 
a successful in vitro oscillator. Tiny amounts of impurities, such as proteases and 
ATPases, will abolish the oscillatory phosphorylation of KaiC. By applying protein-
specific purification methods, those three proteins can be purified with sufficiently high 
purity and yield. 
 
2. Equipment 
Temperature-controlled shaking incubator 
Refrigerated centrifuge  
French press 
Fast protein liquid chromatography apparatus (FPLC) 
Nickel (Ni) affinity column (such as 5 ml HiTrap Chelating HP prepacked column from 
GE Healthcare) 
Glutathione-S-transferase (GST) affinity column (such as 5 ml GSTrap HP prepacked 
column from GE Healthcare) 
Anion exchange column (such as 5 ml HiTrap Q HP prepacked column from GE 
Healthcare) 
Desalting column (such as HiPrap 26/10 desalting column from GE Healthcare) 
Membrane protein concentrator (such as an Amicon centrifugal filter) 
Visible spectrophotometer 
Sample changer 
Heat block 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) system (such 
as Mini-PROTEAN from BioRad) 
Gel documentation system 
 
3. Materials 
Sodium chloride (NaCl) 
Magnesium chloride (MgCl2) 
Hydrogen chloride (HCl) 
Soduim hydroxide (NaOH) 
Ethylenediaminetetraacetic acid (EDTA) 
Adenosine triphosphate (ATP) 
Dithiothreitol (DTT) 
Imidazole 
PreScission
TM
 protease (from GE Healthcare)  
Ubiquitin-like-specific protease 1 (Ulp1) 
Bradford reagent  
Tris 
Glycine 
Sodium dodecyl sulfate (SDS) 
Ammonium persulfate (APS) 
Acrylamide (such as 30% acrylamide:bis solution, 29:1 from BioRad) 
Bromophenol blue 
Glycerol 
Guanidinium chloride 
Kanamycin 
Isopropyl β-D-thiogalactopyranoside (IPTG) 
Luria-Bertani broth (LB) 
Escherichia coli (BL21DE3) 
InstantBlue
TM
 coomassie stain (From Expedeon) 
 
 
3.1. Solutions & buffers 
Ni buffer A 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.0 20 mM   1 M  10 ml 
NaCl   500 mM   5 M  50 ml 
Imidazole  500 mM   5 M  50 ml 
Add water up to 500 ml final volume and pass through a 0.45-μm filter 
 
Ni buffer B 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.0 20 mM   1 M  10 ml 
NaCl   500 mM   5 M  50 ml 
Imidazole  5 mM    5 M  5 ml 
Add water up to final volume 500 ml and pass through a 0.45-μm filter 
 
Desalting buffer 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.0 20 mM   1 M  10 ml 
NaCl   150 mM   5 M  15 ml 
Add water up to final volume 500 ml and pass through a 0.45-μm filter 
 
Anion exchange buffer A 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.0 20 mM   1 M  10 ml 
NaCl   20 mM   5 M  2 ml 
Add water up to final volume 500 ml and pass through a 0.45-μm filter 
 
Anion exchange buffer B 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.0 20 mM   1 M  10 ml 
NaCl   1 M    5 M  100 ml 
Add water up to final volume 500 ml and pass through a 0.45-μm filter 
 
In vitro reaction buffer 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.0 20 mM   1 M  5 ml 
NaCl   150 mM   5 M  7.5 ml 
MgCl2   5 mM    1 M  1.25 ml 
EDTA   0.5 mM   500 mM 0.25 ml 
ATP   1 mM    10 mM 25 ml 
Add water up to final volume 250 ml and pass through a 0.45-μm filter  
GST buffer A 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.3 50 mM   1 M  10 ml 
NaCl   150 mM   5 M  6 ml 
MgCl2   5 mM    1 M  1ml 
EDTA   1 mM    500 mM 0.4 ml 
ATP   5 mM    10 mM 100 ml 
Add water up to final volume 200 ml and pass through a 0.45-μm filter 
 
GST buffer B 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.3 50 mM   1 M  2.5 ml 
NaCl   150 mM   5 M  1.5 ml 
MgCl2   5 mM    1 M  0.25ml 
EDTA   1 mM    500 mM 0.1 ml 
ATP   1 mM    10 mM 5 ml 
Glutathione   6 mM    100 mM 3 ml 
Add water up to final volume 50 ml and pass through a 0.45-μm filter  
GST buffer C 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.3 50 mM   1 M  10 ml 
NaCl   150 mM   5 M  6 ml 
MgCl2   5 mM    1 M  1 ml 
EDTA   1 mM    500 mM 0.4 ml 
ATP   1 mM    10 mM 20 ml 
Add water up to final volume 200 ml and pass through a 0.45-μm filter  
10× loading dye 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 7.5 100 mM   1 M  1 ml 
DTT   200 mM   1 M  2 ml 
SDS   4 %    40 %  1 ml 
Bromophenol Blue 0.2 %    2 %  1 ml 
Glycerol  30 %    60 %  5 ml 
Add water to final volume 10 ml  
 Tris-Glycine gel buffer 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 8.5 25 mM   1 M  25 ml 
Glycine  200 mM   2 M  100 ml 
SDS   1 %    40 %  25 ml 
Add water to final volume 1 L  
 
Acrylamide running gel 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 8.8 400 mM   1.5 M  8 ml 
Acrylamide  6.5 %    30 %  6.5 ml 
SDS   0.1 %    40 %  0.075 ml 
APS   0.1 %     10 %     0.3 ml 
TEMED  0.03 %    100 %  0.009 ml 
Add water to final volume 30 ml and pass through a 0.45-μm filter 
 
Acrylamide stacking gel 
Component  Final concentration  Stock  Amount 
Tris-HCl, pH 6.8 60 mM   500 mM 1.8 ml 
Acrylamide  5 %    30 %  2.5 ml 
SDS   0.1 %    40 %  0.038 ml 
APS   0.05 %     10 %     0.075 ml 
TEMED  0.1 %    100 %  0.015 ml 
Add water to final volume 15 ml and pass through a 0.45-μm filter 
 
4. Protocol 
 
4.1. Duration 
Preparation  3-5 days 
Protocol 7-8 days 
 
4.2. Preparation 
Kai protein overexpression plasmids were prepared with some modification of 
pET28a(+) and pET41a(+) vectors. For KaiA and KaiB, sequences that encode SUMO-
KaiA or SUMO-KaiB were inserted in between NdeI and HindIII restriction sites on 
pET28a(+). For KaiC, the PreScission
TM
 protease cutting sequence (LEVLFEQGP) was 
encoded before the start codon of KaiC and inserted in between the NcoI and HindIII 
sites on pET41a(+). Each plasmid was confirmed by sequencing and introduced into E. 
coli (BL21DE3) for protein overexpression. 
 
5. Step 1 Express KaiA or KaiB in E. coli 
 
5.1 Overview 
The overexpressed KaiA and KaiB will be prepared for further purification. 
 
5.2. Duration 
12 h 
1.1 Inoculate 1L LB (containing the appropriate antibiotic) with transformed E. coli 
(BL21DE3) and grow the culture with vigorous shaking (~ 250 RPM) at 37°C 
until the absorbance reaches A600nm = 0.7.  
1.2 Add 1 ml of 1 M IPTG to induce overexpression of recombinant KaiA or KaiB 
and incubate an additional 6 h under the same conditions. 
1.3 Harvest the cells by centrifugation for 10 min in a refrigerated centrifuge at 
5,500 × g 
1.4 Remove the supernatant fraction and store the pellet at -80°C. 
 
5.3. Tip  
Add anti-foam to help aeration by preventing foam. 
 6. Step 2 Express KaiC in E. coli. 
 
6.1 Overview 
KaiC requires slower induction than KaiA or KaiB to obtain abundant folded, soluble 
protein. The overexpressed KaiC will be prepared for further purification. 
 
6.2. Duration 
24 h 
2.1 Inoculate 1L LB (containing the appropriate antibiotic) with transformed E. coli 
(BL21DE3) and grow the culture at 37°C until the absorbance reaches A600nm = 
0.6. 
2.2 Cool the culture down to 25°C. 
2.3 Add 1 ml of 100 mM IPTG to induce overexpression of recombinant KaiC and 
incubate the culture with shaking (~ 150 RPM) at 25°C for an additional 16 h. 
2.4 Harvest the cells by centrifugation for 10 min in a refrigerated centrifuge at 
5,500 × g 
2.5 Remove the supernatant fraction and store the pellet at -80°C. 
 
6.3. Tip  
Room temperature incubation (~23°C) can be used if temperature control is unavailable. 
Cool down completely before inducting with IPTG. Incomplete cooling causes low 
yield.  
 
7. Step 3 Purification of KaiA or KaiB 
 
7.1 Overview 
Purify KaiA and KaiB with high purity and yield by using a series of FPLC columns. 
 
7.2. Duration 
36 h 
3.1 Resuspend KaiA or KaiB pellets (saved in Step 1.4) in 60 ml of Ni buffer A. 
3.2 Pass the resuspended cells twice through a chilled French press cell with 
16,000 PSI. 
3.3 Spin the lysates for 60 min in a refrigerated centrifuge at 20,000 × g. 
3.4 Filter the supernatant fraction through a 0.45-μm filter.  
3.5 Inject the filtered supernatant into a Ni affinity column using FPLC with a 2 
ml/min flow rate. 
3.6 Wash the column with 25 mL Ni buffer A. 
3.7 Elute His-tagged KaiA or KaiB with a 0 – 80% Ni buffer B gradient over 30 
min. 
3.8 Identify the protein-positive fractions from step 3.7 by Absorbance at 280 nm 
and combine positive fractions. Run the combined protein sample through a 
desalting column using Desalting buffer with 4 ml/min flow rate. 
3.9 Identify the protein-positive fractions from step 3.8 by Absorbance at 280 nm 
and combine positive fractions. Inject the combined protein sample into an 
anion exchange column using FPLC with a 2 ml/min flow rate. 
3.10 Wash the column with 25 ml Anion exchange buffer A. 
3.11 Elute His-tagged KaiA or KaiB with a 0 – 80% Anion exchange buffer B 
gradient over 30 min. 
3.12 Identify the protein-positive fractions from step 3.11 by Absorbance at 280 nm 
and combine positive fractions. Add 1 ml of 1 M NaCl and 0.1 ml of 100 μM 
Ulp1 per each 10 ml of combined protein-positive sample. 
3.13 Incubate the mixture for 16 h at 4°C. 
3.14 Inject the incubated mixture into a Ni affinity column using FPLC with a 2 
ml/min flow rate and collect the flow-through. This step will retain the tags on 
the column and allow untagged KaiA and KaiB to pass through. 
3.15 Wash the column with 5 ml Ni buffer A and continue to collect the flow-
through. 
3.16 Inject the flow-through into a desalting column and wash out continuously 
using Anion exchange buffer A with a 4 ml/min flow rate until all protein-
positive fractions are collected. Identify the protein-positive fractions by 
Absorbance at 280 nm and combine positive fractions. 
3.17 Inject the combined positive fraction into anion exchange column using FPLC 
with 2 ml/min flow rate. 
3.18 Wash the column with 25 ml Anion exchange buffer A. 
3.19 Elute KaiA or KaiB with a 0 – 80% Anion exchange buffer B gradient for 30 
min. 
3.20 Identify the protein-positive fractions from step 3.19 by Absorbance at 280 nm 
and combine positive fractions. Inject the combined fraction into a desalting 
column and wash out continuously using In vitro reaction buffer with a 4 
ml/min flow rate until all protein-positive fractions are collected. 
3.21 Concentrate the combined protein-positive fraction from step 3.20 using a 
membrane protein concentrator (such as an Amicon centrifugal filter). KaiA 
and KaiB can be concentrated up to 150 μM and 50 μM, respectively. 
3.22 Pass the concentrated protein through a 0.25 μm syringe filter. 
3.23 Measure the concentration by Bradford assay.  
3.24 Store protein at -80°C. 
 
7.3. Tip  
The purification procedure should be performed at room temperature to obtain high 
purity.  
7.4. Tip  
Dialysis can be used instead of a desalting column.  
7.5. Tip  
The second affinity column (Step 3.14 - 3.15) also helps to remove impurities and is 
essential for obtaining the purity needed for the in vitro oscillator; this step should not 
be skipped. 
 8. Step 4 Purification of KaiC 
 
8.1 Overview 
Purify KaiC with high purity and yield by using a series of FPLC columns. 
 
8.2. Duration 
36 h 
4.1 Resuspend KaiC pellets (saved in Step 2.5) in 60 ml of GST buffer A. 
4.2 Follow Steps 3.2 to 3.4 as for KaiA and KaiB purification. 
4.3 Inject the filtered supernatant into a GST affinity column using FPLC with a 1 
ml/min flow rate. 
4.4 Wash the column with 90 ml GST buffer A. 
4.5 Elute GST-tagged KaiC with 12 ml GST buffer B and collect the entire elution 
volume. 
4.6 Add 10 μl of PreScissionTM protease per each 12 μl of the collected eluent. 
4.7 Incubate the KaiC mixture for 16 h at 4°C. 
4.8 Inject the incubated KaiC mixture into a desalting column and wash out using 
GST buffer C with a 4 ml/min flow rate until all protein-positive fractions are 
collected. 
4.9 Inject the protein-positive fractions into a GST affinity column with a 1 ml/min 
flow rate and take the flow-through. This step will retain the tag on the column 
and allow untagged KaiC to pass through. 
4.10 Wash the column with 5 ml GST buffer C and continue to collect the flow-
through. Combine the flow-through from Step 4.9 and 4.10. 
4.11 Inject the combined flow-through into a desalting column and wash out using 
In vitro reaction buffer with a 4 ml/min flow rate until all protein-positive 
fractions are collected. 
4.12 Concentrate the combined protein-positive fraction from step 4.11 using a 
membrane protein concentrator (such as an Amicon centrifugal filter). KaiC  
can be concentrated to ~ 15 μM. 
4.13 Follow from Step 3.22 to 3.24 as for KaiA and KaiB purification. 
 
8.3. Tip  
The purification procedure should be performed at room temperature to obtain high 
purity.  
 
8.4. Tip  
Using a desalting column instead of dialysis may increase yield by preventing 
precipitation.  
 
9. Step 5 In vitro oscillation reaction 
 9.1 Overview 
The phosphorylation states of KaiC can be observed to oscillate with a 24-hour period 
by mixing KaiA, KaiB, KaiC, and ATP at 30°C.  
 
9.2. Duration 
76 h 
5.1 Mix 1.2 μM KaiA, 3.5 μM KaiB, 3.5 μM KaiC, and Kanamycin (10 μg/ml 
final concentration) in In vitro reaction buffer.  
5.2 Incubate the reaction mixture at 30°C. 
5.3 Take 20 μl aliquots of reaction mixture every 2 h for 3 days and add 2 μl 10× 
loading dye. For an SDS-PAGE, at least a 5 μl aliquot is needed. 
5.4 Freeze each sample at -20°C as it is collected until the reaction is complete.  
5.5 Keep all samples at -20°C prior to SDS-PAGE analysis. 
 
9.3. Tip  
The total reaction volume can be modified to provide the number of samples desired in 
Step 5.3 to run at least one gel of the timecourse. 
 
10. Step 6 SDS-PAGE 
 
10.1 Overview 
SDS-PAGE (6.5 % polyacrylamide gel) is able to separate phosphorylated and 
unphosphorylated forms of KaiC. 
 
10.2. Duration 
2 h 
6.1 Prepare eight 15-well polyacrylamide gels with Acrylamide running gel and 
Acrylamide stacking gel. 
6.2 Mount the gel in the apparatus, place the entire apparatus into a water-tight 
high-sided tray, and fill the reservoir with Tris-Glycine buffer. Remove all 
bubbles at the bottom of the gel. 
6.3 Take out comb and remove all bubbles in the wells. Load the samples (saved in 
Step 5.4) onto the gel. 
6.4 Pack ice around the outside of the SDS-PAGE apparatus. 
6.5 Run the gel at 60 V for 30 min and at 140 V for 100 min. 
6.6 Put the gel in InstantBlueTM coomassie stain solution. 
6.7 Stain overnight and destain with water until bands are clearly visible. 
 
10.3. Tip  
Load 4 to 5 μl of sample in each of the 13 interior wells. Gel “smiling” can be avoided 
by loading dye only, rather than sample, in the outside wells on either end. The resulting 
straight line of bands will facilitate quantification. 
10.4. Tip  
The number of gels on Step 6.1 and the time on Step 6.5 calculated based on Mini-
PROTEAN form BioRad. 
 
11. Step 7 Densitometry 
 
11.1 Overview 
This is an easy quantification method for determining the phosphorylation level of KaiC 
in order to graph the oscillation.  
 
11.2. Duration 
1 h 
7.1 Capture a high-resolution image of the stained gel. 
7.2 Measure the density of each band with National Institutes of Health (NIH) 
ImageJ. 
7.3 Combine values for bands that represent phosphoforms and calculate % 
phosphorylated KaiC (P-KaiC). 
7.4 Draw a graph that plots % P-KaiC vs. time. 
 
11.3. Tip  
Follow ImageJ user guide on NIH website 
(http://imagej.nih.gov/ij/docs/guide/index.html) to measure the density of each band. 
 
11.4. Tip  
PeakFit software can be used instead of NIH ImageJ. 
 
Figure 1. In vitro oscillation flowchart: 
Figure 2. Coomassie-stained SDS-PAGE image of KaiC phosphorylation cycles. The 
samples were taken every 4 h for 2 days. Four phosphoforms of KaiC can be separated 
with the method introduced here. ST-KaiC, S431 and T432 KaiC double phosphoform; 
T-KaiC, T432 KaiC phosphoform; S-KaiC, S431 KaiC phosphoform; and U-KaiC, 
unphosphorylated KaiC. 
  
 
  
12. Detection of protein phosphorylation forms from in vivo cell extracts  
Separation of the phosphoforms of KaiC, which is phosphorylated on Ser/Thr residues, 
from total soluble cell protein extracts can be facilitated by use of Phos-tag
™
 reagent in 
a modified immunoblotting protocol. Phos-tag
TM
 SDS-PAGE allows separation of 
phospho-states by reagent binding to phosphate groups and retardation of 
phosphorylated proteins during electrophoresis. This technique can also be applied to 
phosphorylated histidine kinases and response regulators, for which the inherent lability 
of phospho-His and phospho-Asp and the lack of phospho-specific antibodies to these 
residues has hindered in vivo detection of the phosphorylated states of these proteins 
(Barbieri & Stock, 2008). The requirement for specific antibodies can be circumvented 
by the addition of epitope tags, although this approach has not yet been reported in 
Phos-tag
™ 
assays. Phos-tag
™ 
acrylamide separations require optimization of gel 
composition for each protein studied. Ranges of 25 to 50 μM of Phos-tag™ acrylamide 
reagent and 50 μM Mn2+ are good starting references, but optimal concentrations must 
be determined empirically to obtain sharp banding. However, even with substantially 
distorted bands, if sufficient separation of unphosphorylated and phosphorylated protein 
bands is achieved, quantification of the fraction of phosphorylated proteins can be 
accurately estimated using image analysis software (Gutu & O'Shea, 2013). 
The following protocol has been used to analyze the in vivo phosphorylation of KaiC, 
RpaA and RpaB in S. elongatus cells subjected to 12:12 LD cycles (Fig. 3). It should 
form a suitable starting protocol that can be optimized for the protein under study. 
13. Equipment 
Temperature-controlled lighted incubator 
Refrigerated centrifuge 
Cell homogenizer or benchtop vortexer 
Rotary shaker 
Power supply 
Electrophoretic apparatus for SDS-PAGE 
Protein blotting (Wet transfer) apparatus 
Standard blotting accessories (filter paper, blotting membrane) 
Imaging equipment and software 
14. Materials 
29:1 acrylamide: N, N′-methylene-bis-acrylamide 
deionized distilled water 
1.5 M Tris-Cl pH 8.8 
0.5 M Tris-Cl pH 6.8 
sodium dodecyl sulfate (SDS)  
100% isopropanol or saturated butanol 
ammonium persulfate (APS) 
TEMED 
Phos-tag
TM
 acrylamide AAL-007 (Wako Chemicals) 
10 mM MnCl2 
DTT 
bromphenol blue 
glass beads (100-300 μm diameter) 
Tris 
Glycine 
Methanol 
Bradford reagent 
EDTA (0.5 M) 
Antibodies to proteins of interest 
Secondary antibodies (for example horseradish peroxidase, HRP-linked) and 
chemiluminescent substrate for detection 
14.1. Solutions and Buffers 
TBS-T: 
100 mL 10X Tris-buffered saline (TBS)  
1 mL Tween-20 
water to 1 L 
Lysis Buffer: 
25 mM Tris pH 8.0 
0.5 mM EDTA 
1 mM DTT and bacterial protease inhibitor cocktail (Sigma) 
Transfer Buffer: 
2.2 g CAPS 
8.33 μL 10N NaOH 
100 mL methanol 
deionized water to 1 L 
15. Protocol 
15.1 Duration 
Preparation: 3-5 days, depending on duration of sampling 
Protocol: 2 days 
17. Step 1 Preparation 
17.1 Overview 
Cast Phos-tag
TM
 acrylamide gels, entrain cyanobacterial strains and collect samples 
 1.1. Phos-tag
™
acrylamide SDS mini gels are prepared using a discontinuous 
buffer system (refer to materials section 3.1 for gel preparation, increasing 
resolving gel acrylamide concentration to 10% w/v). The resolving gel consists 
of 10% (w/v) 29:1 acrylamide: N, N′-methylene-bis-acrylamide containing Tris-
HCl pH 8.8, 0.1% SDS, supplemented with 25 μM of Phos-tag™acrylamide 
reagent and 50 μM Mn2+. Overlay the gel with a 2 mm layer of saturated 
butanol, or layer with isopropanol to exclude oxygen and ensure a flat interface 
between the resolving and stacking gels. After polymerization, rinse the 
isopropanol or butanol from the top of the gel with water, and drain the water by 
inverting the gel. Prepare the stacking gel using 4% (w/v) acrylamide:bis-
acrylamide, Tris-HCl pH 6.8 and 0.1% SDS. Pre-chill acrylamide gels at 4°C 
prior to electrophoresis. 
1.2. Entrain S. elongatus cells for two 12:12 LD cycles, move to constant light, 
and subsequently sample at chosen time points. 
1.3. At each time point, harvest 10-15 mL of cells (grown to an optical density 
of  A750=0.1-0.75) by centrifugation at 6000 x g for 5 min at 4ºC. Carefully 
remove all residual growth medium from cell pellet. Quickly freeze each cell 
pellet and store at -80ºC until ready to prepare lysates. 
1.4. Resuspend the cell pellet in 30-80 µL of lysis buffer (25 mM Tris pH 8.0, 
0.5 mM EDTA, 1 mM DTT and bacterial protease inhibitor cocktail (Sigma)). 
Add glass beads (0.1-0.3 micron diameter) equivalent to one-third of the 
volume. Cell lysis is achieved with 2 cycles of 1 min in a homogenizer 
(BeadBeaterBioSpec) with 1 min cooling between cycles. Alternatively, cells 
may be lysed using a benchtop vortexer at maximum setting with ten cycles 
alternating 30 seconds vortexing/30 seconds cooling on ice.  
1.5. Centrifuge cell extract at 10 000 x g for 5 min at 4ºC to pellet unbroken 
cells, cellular debris and beads. Transfer the blue-green supernatant to a new 
tube and use an aliquot to quantify protein concentration using a Bradford assay. 
Samples may be used immediately for gel loading, or stored at -20ºC. 
17.1 Tip 
For proteins with heat-labile phospho-Asp or phospho-His residues, keep samples on 
ice after extraction and do not heat prior to gel loading. To obtain optimal levels of 
phosphorylated protein, proceed directly to electrophoresis and do not subject cell 
extracts to freeze-thaw cycles.  
17.2 Tip 
Samples must be prepared in buffer without phosphate. Do not substitute phosphate-
buffered saline (PBS) for TBS during resuspension of cell pellets.   
 
 
18. Step 2 Electrophoresis and Blotting 
18.1 Overview 
Load and run Phos-tag acrylamide gels and detect proteins by immunobloting 
 
2.1. Load  2-5 µg of protein extract in SDS sample buffer per lane (for KaiC 
detection) and run at 90V 4ºC for approximately 3 hours in a Tris/Glycine/SDS 
buffer. 
2.2 Incubate gels twice for 5 min at RT in transfer buffer solution 
(Tris/Glycine/Methanol supplemented with 1 mM EDTA), then twice more in 
standard transfer solution without EDTA. 
2.3. Transfer proteins from gel to PVDF membrane by wet electroblotting (tank 
transfer). Transfer at 4ºC and 100V for at least 3 hours is recommended.  
2.4. Block the membrane with 2.5% nonfat dry milk (NFDM)/Tris-buffered 
saline (TBS) + 0.1% Tween-20 for 1 hour at RT and then incubate with Anti-
KaiC (1:2 000) overnight at 4°C on a rotary shaker. Then, rinse the membrane 
twice with TBS and incubate with HRP-linked secondary antibody (1: 10 000) 
in NFDM/TBS-T for 1 hour at RT.  
2.5 Develop blot using SuperSignal West Femto Maximum Sensitivity Substrate 
(Thermo Scientific) according to the manufacturer’s directions. For examples 
shown in Figure 3, chemiluminescence was detected using an Alpha Innotech 
FluorChem® HD2 Imaging System (Alpha Innotech, San Leandro, CA) (cf. Fig. 
3B). 
2.6. Perform image analysis to quantify band intensity using NIH ImageJ 
software. (cf. Fig. 3 B). 
18.2 Tip 
Resolution of multiple KaiC phospho-states may be obtained by running gels at lower 
current for an extended time and/or increasing concentration of Phos-tag
TM
 acrylamide 
reagent. 
 
 
Figure 3. Detection of protein phosphorylation using Phos-tag acrylamide from whole-
cell soluble protein extracts A) Immunoblot showing separation of phosphorylated and 
unphosphorylated KaiC after Phos-tag
TM
 SDS-PAGE. Protein samples were collected 
every eight hours in constant light after entrainment to two 12-h light:dark (LD) cycles. 
B) Quantification of P~RpaA and P~RpaB fractions from immunoblots. Specific 
detection of either P~RpaB and RpaB (top panel) or P~RpaA and RpaA (bottom panel) 
with anti-RpaB or anti-RpaA polyclonal antibodies, respectively, is shown. The white 
and black boxes represent, respectively, light and dark periods. Boxes corresponding to 
first two LD cycles are not drawn to scale. 
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Spain. 
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